[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "SHOULD ROW fractionation method SH MS ISA EM BE FDR OR COLUMN DTT cell type MAJOR PMID alkylation reagent NT AC PROTEOMICS cleavage agent details exclamation CL collision energy MT MHC MC TIP HEREIN THAT DJ organism IAA SRM PEPTIDESEQ ZFA TO DISCLAIMS AS IS biosample accession number PP CS INITIATIVE USE organism part MUST disease stage data file HUPO III instrument NOTE QY REQUIRES individual sex MAGE CV EW LI EFO technical replicate ANY mass XML THE depletion PATO CLO WILL label LC IMPLIED pooled sample PARTICULAR CID BUT NCE PRIDE XL biological replicate JA PS ancestry category RFC replicate CF MIAME MERCHANTABILITY MINOR WARRANTY INFORMATION FOR ... IMPORTANT SWATH BMC ENVO spiked compound PTM HF TAB VCF IDF URI BTO INCLUDING SDRF UBERON MS:1001251 disease developmental stage MONDO TMT CT PSI README age NOT NCBI OPTIONAL file your DOID PRM RECOMMEND CN CPTAC REQUIRED VK HTML SN II LIMITED dissociation method ID MOD RIGHTS PURPOSE PO CELL FITNESS PMCID ALL BRENDA reduction reagent PRIDE:0000659 DDA COULD EBI DIA STANDARDS INFRINGE source name_ and _assay name OF WARRANTIES RAW proteomics data acquisition method fraction identifier HANCESTRO characteristics source name EXPRESS RECOMMENDED MANDATORY MAY sample SILAC SP HCD SHALL PATCH URL TA"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "SHOULD ROW fractionation method SH MS ISA EM BE FDR OR COLUMN DTT cell type MAJOR PMID alkylation reagent NT AC PROTEOMICS cleavage agent details CL collision energy MT MHC MC HEREIN THAT DJ organism IAA SRM PEPTIDESEQ ZFA TO DISCLAIMS AS IS biosample accession number PP CS INITIATIVE USE organism part MUST disease stage data file HUPO III instrument QY REQUIRES individual sex MAGE CV EW LI EFO technical replicate ANY mass THE depletion PATO CLO WILL label LC IMPLIED pooled sample PARTICULAR CID BUT NCE PRIDE XL biological replicate JA PS ancestry category RFC CF MIAME MERCHANTABILITY MINOR WARRANTY INFORMATION FOR ... SWATH BMC ENVO spiked compound PTM HF TAB VCF IDF URI BTO INCLUDING SDRF UBERON MS:1001251 disease MONDO TMT CT PSI README age NOT NCBI OPTIONAL DOID PRM RECOMMEND CN CPTAC REQUIRED VK HTML SN II LIMITED dissociation method MOD RIGHTS PURPOSE PO CELL FITNESS PMCID ALL BRENDA reduction reagent PRIDE:0000659 DDA COULD EBI DIA STANDARDS INFRINGE OF WARRANTIES RAW proteomics data acquisition method fraction identifier HANCESTRO EXPRESS RECOMMENDED MANDATORY MAY SILAC SP HCD SHALL PATCH URL TA"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html",
    "section": "Sample Metadata Convention",
    "keywords": "SHOULD MONDO:0004975 MONDO:0100096 CL:0000236 UBERON:0002113 MONDO:0004989 UBERON:0000310 cell type CL:0000451 NSG MONDO:0005148 COVID exclamation CL CL:0000235 TIP synthetic peptide organism UBERON:0002097 CL:0000182 MONDO:0005138 UBERON:0000955 enrichment process MONDO:0004946 PATO:0000383 MONDO:0008383 organism part MUST disease model CL:0000788 MONDO:0005301 NOTE individual CL:0000787 sex CL:0000913 UBERON:0001155 MONDO:0005575 CL:0000624 CML CL:0000084 PATO:0000461 EFO CSF MONDO:0005180 CL:0000233 lib CL:0000815 depletion PATO CL:0000623 MONDO:0005105 UBERON:0001088 CL:0000540 xenograft biological replicate DSS ancestry category CL:0000057 UBERON:0000178 UBERON:0002048 UBERON:0002107 IMPORTANT PATO:0000384 PTM UBERON:0000948 CL:0000625 SDRF CL:0000066 UBERON developmental stage disease MONDO CL:0000813 age NCBI UBERON:0001359 DOID CL:0000232 UBERON:0001977 CL:0000898 NK ID PO ALL compound PATO:0001340 UBERON:0001969 CL:0000576 HANCESTRO source name MAY PDX APP URL"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html#sample-metadata-conventions",
    "section": "Sample Metadata Convention",
    "keywords": "SHOULD MONDO:0004975 MONDO:0100096 CL:0000236 UBERON:0002113 MONDO:0004989 UBERON:0000310 cell type CL:0000451 NSG MONDO:0005148 COVID CL CL:0000235 synthetic peptide organism UBERON:0002097 CL:0000182 MONDO:0005138 UBERON:0000955 enrichment process MONDO:0004946 PATO:0000383 MONDO:0008383 organism part MUST disease model CL:0000788 MONDO:0005301 individual CL:0000787 sex CL:0000913 UBERON:0001155 MONDO:0005575 CL:0000624 CML CL:0000084 PATO:0000461 EFO CSF MONDO:0005180 CL:0000233 CL:0000815 depletion PATO CL:0000623 MONDO:0005105 UBERON:0001088 CL:0000540 xenograft biological replicate DSS ancestry category CL:0000057 UBERON:0000178 UBERON:0002048 UBERON:0002107 PATO:0000384 PTM UBERON:0000948 CL:0000625 SDRF CL:0000066 UBERON developmental stage disease MONDO CL:0000813 age NCBI UBERON:0001359 DOID CL:0000232 UBERON:0001977 CL:0000898 NK ID PO ALL compound PATO:0001340 UBERON:0001969 CL:0000576 HANCESTRO source name MAY PDX APP URL"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html",
    "section": "Human Metadata Convention",
    "keywords": "Ann Arbor stage NCIT:C27970 NCIT:C28079 menopausal status NCIT:C15262 MONDO:0004979 MONDO:0005300 NCIT:C81327 NCIT:C71732 IV MONDO:0005148 exclamation gestational age UO NCIT:C16358 body mass index organism CHEBI:28748 NCIT:C18206 HANCESTRO:0005 NCIT:C81328 NCIT:C15445 NCIT:C14168 height PD medication history ER disease stage secondary condition NCIT:C53553 organism part pregnancy status III BMI breast cancer subtype time post treatment ethnicity NCI HANCESTRO:0010 MONDO:0002050 weight NOTE individual NCIT:C28076 sex NCIT:C53556 NCIT:C53555 NCIT:C65107 diet treatment status EFO treatment response treatment NCIT NCIT:C27966 NCIT:C18058 NCIT:C62723 NCIT:C15313 NCIT:C65106 NCIT:C28077 HIPAA ancestry category NCIT:C14169 GDPR pre-existing condition MONDO:0011122 NCIT:C28054 PREFERRED IMPORTANT MONDO:0005044 prior treatment AJCC smoking status dose NCIT:C14174 sampling time point tumor grade SDRF NCIT:C15632 disease ACE HANCESTRO:0006 NCIT:C28078 MONDO age HANCESTRO:0009 NCIT:C27971 TNM staging NCIT:C18213 II ID NCIT:C53554 NCIT:C14167 NCIT:C15329 Dukes stage CHEBI:27899 MONDO:0004995 compound NCIT:C68804 CHEBI:41774 TNM alcohol consumption NCIT:C4870 HANCESTRO PR CHEBI:6801 NCIT:C65108"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html#human-sample-metadata-convention",
    "section": "Human Metadata Convention",
    "keywords": "Ann Arbor stage NCIT:C27970 NCIT:C28079 menopausal status NCIT:C15262 MONDO:0004979 MONDO:0005300 NCIT:C81327 NCIT:C71732 IV MONDO:0005148 gestational age UO NCIT:C16358 body mass index organism CHEBI:28748 NCIT:C18206 HANCESTRO:0005 NCIT:C81328 NCIT:C15445 NCIT:C14168 height PD medication history ER disease stage secondary condition NCIT:C53553 organism part pregnancy status III BMI breast cancer subtype time post treatment ethnicity NCI HANCESTRO:0010 MONDO:0002050 weight individual NCIT:C28076 sex NCIT:C53556 NCIT:C53555 NCIT:C65107 diet treatment status EFO treatment response treatment NCIT NCIT:C27966 NCIT:C18058 NCIT:C62723 NCIT:C15313 NCIT:C65106 NCIT:C28077 HIPAA ancestry category NCIT:C14169 GDPR pre-existing condition MONDO:0011122 NCIT:C28054 PREFERRED MONDO:0005044 prior treatment AJCC smoking status dose NCIT:C14174 sampling time point tumor grade SDRF NCIT:C15632 disease ACE HANCESTRO:0006 NCIT:C28078 MONDO age HANCESTRO:0009 NCIT:C27971 TNM staging NCIT:C18213 II ID NCIT:C53554 NCIT:C14167 NCIT:C15329 Dukes stage CHEBI:27899 MONDO:0004995 compound NCIT:C68804 CHEBI:41774 TNM alcohol consumption NCIT:C4870 HANCESTRO PR CHEBI:6801 NCIT:C65108"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html",
    "section": "Data File Metadata Convention",
    "keywords": "SHOULD fraction TMT proteomexchange accession number PSI PP UNIMOD:21 CS precursor mass tolerance MS MUST PRIDE XL UNIMOD:737 PRM MGF URL data file SCIEX UNIMOD:35 UNIMOD:1 KR MS:1001313 MS:1001917 TOF REQUIRED TS FTP MS:1001309 ST scan window upper limit LTQ ID MOD MS2 analyzer type instrument fragment mass tolerance modification parameters RPPA NT AC scan window lower limit MSD CF MS1 scan range DDA PRIDE:0000663 NOTE DIA cleavage agent details exclamation IMPORTANT MT file uri RAW MS:1001306 MS:1001251 ELISA TIP MS:1001303 proteomics data acquisition method fraction identifier HF SRM RECOMMENDED UNIMOD sample technical replicate SILAC MM MRM URI UNIMOD:4 label SDRF TA"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html#data-file-metadata-conventions",
    "section": "Data File Metadata Convention",
    "keywords": "SHOULD TMT proteomexchange accession number PSI PP UNIMOD:21 CS precursor mass tolerance MS MUST PRIDE XL UNIMOD:737 PRM MGF URL data file SCIEX UNIMOD:35 UNIMOD:1 KR MS:1001313 MS:1001917 TOF REQUIRED TS FTP MS:1001309 ST scan window upper limit LTQ ID MOD MS2 analyzer type instrument fragment mass tolerance modification parameters RPPA NT AC scan window lower limit MSD CF MS1 scan range DDA PRIDE:0000663 DIA cleavage agent details MT file uri RAW MS:1001306 MS:1001251 ELISA MS:1001303 proteomics data acquisition method fraction identifier HF SRM RECOMMENDED UNIMOD technical replicate SILAC MM MRM URI UNIMOD:4 label SDRF TA"
  }
]